Results 101 to 110 of about 5,633 (170)

Therapeutic challenges in relapsing cutaneous and visceral leishmaniasis caused by Leishmania (Mundinia) martiniquensis in patients with advanced HIV disease from Southern Thailand. [PDF]

Trop Med Health
Phadungsaksawasdi K, Songumpai N, Swasdivanich C, Rongngern P, Borriboon T, Savigamin C, Brownell N, Kraivichian K, Noppakun N, Siriyasatien P, Asawanonda P, Preativatanyou K.   +11 more
europepmc   +1 more source

Evaluating LeishPepThera (PepA) as an immuno-therapeutic for <i>Leishmania major</i> infection. [PDF]

iScience
Khandibharad S, Singh S.
europepmc   +1 more source

Cutaneous leishmaniasis: epidemiology, treatment access and translational challenges of topical therapies. [PDF]

Front Microbiol
Carrer DC, Papera F, Ríos DN.
europepmc   +1 more source

Insights on genomic profiles of drug resistance and virulence in a cohort of Leishmania infantum isolates from the Mediterranean area. [PDF]

Parasit Vectors
Carrasco-Martin M, Martí-Carreras J, Gómez-Ponce M, Alcover MM, Roura X, Ferrer L, Baneth G, Bruno F, Chicharro C, Cordeiro-da-Silva A, Cristovão J, Di Muccio T, Maia C, Moreno J, Priego A, Roca-Geronès X, Santarem N, Soriano AV, Vitale F, Yasur-Landau D, Francino O.   +20 more
europepmc   +1 more source

Light, Dyes, and Action: Photodynamic Inactivation of <i>Leishmania amazonensis</i> Using Methylene Blue, New Methylene Blue, and Novel Ruthenium-Based Derivatives. [PDF]

Biology (Basel)
Vasco-Dos-Santos DR, Vacani-Martins N, Silva FCMD, Alves LA, Rocha ZND, Henriques-Pons A, Torres-Santos EC, Vannier-Santos MA.   +7 more
europepmc   +1 more source

Investigation of the antifungal activity of panobinostat, tamoxifen, and miltefosine alone and in combination with some conventional antifungal drugs against fluconazole-resistant <i>Candida</i> species. [PDF]

Iran J Microbiol
Amirzadeh-Ghasemi F, Ghazvini RD, Khodavaisy S, Hashemi SJ, Ahmadi A, Ardi P, Abastabar M, Roostaei D, Rafat Z.   +8 more
europepmc   +1 more source

Lem3, a phospholipid flippase subunit, influences <i>Candida albicans</i> pathogenicity through maintenance of plasma membrane asymmetry. [PDF]

Microbiol Spectr
Agrawal P, Kumar P, Ali B, Nabeela S, Ikeh MAC, Morschhäuser J, Andes DR, Nobile CJ, Prasad R, Uppuluri P, Panwar SL.   +10 more
europepmc   +1 more source

Optimization and prioritization of paediatric drugs for visceral leishmaniasis. [PDF]

Front Pediatr
Masini T, Maia-Elkhoury ANS, Mondal D, Olliaro P, Paudel KN, Penazzato M, Branco Valadas SYO, Yajima A, Beshah A, Warusavithana S, Jain S.   +10 more
europepmc   +1 more source

Osh2 mediates <i>Candida</i> species resistance to miltefosine by regulating zymosterol accumulation. [PDF]

Antimicrob Agents Chemother
Wu Y, Dai Y, Lu H, Jiang X, Wang Y.
europepmc   +1 more source

New and Investigational Treatment Options for Dermatomycosis in the Era of Antifungal Resistance. [PDF]

J Fungi (Basel)
Gupta AK, Liddy A, Wang T.
europepmc   +1 more source